M. Guillermo-Roman

Efficacy and safety of convalescent plasma versus standard care in hospitalized patients with COVID-19 from the Peruvian Social Security Health System: open-label, randomized, controlled clinical trial

J. L. Maguiña, Y. Hurtado-Roca, R. Araujo-Castillo, 2022, medRxiv.

Humoral response after a BNT162b2 heterologous third dose of COVID-19 vaccine following two doses of BBIBP-CorV among healthcare personnel in Peru

D. Urrunaga-Pastor, C. Díaz-Vélez, J. L. Maguiña, 2023, Vaccine: X.